These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 26719378)
1. Comparing the Diagnostic Potential of 68Ga-Alfatide II and 18F-FDG in Differentiating Between Non-Small Cell Lung Cancer and Tuberculosis. Kang F; Wang S; Tian F; Zhao M; Zhang M; Wang Z; Li G; Liu C; Yang W; Li X; Wang J J Nucl Med; 2016 May; 57(5):672-7. PubMed ID: 26719378 [TBL] [Abstract][Full Text] [Related]
2. A Pilot Study of Zhou Y; Gao S; Huang Y; Zheng J; Dong Y; Zhang B; Zhao S; Lu H; Liu Z; Yu J; Yuan S Sci Rep; 2017 Jun; 7(1):2877. PubMed ID: 28588317 [TBL] [Abstract][Full Text] [Related]
3. Wu J; Wang S; Zhang X; Teng Z; Wang J; Yung BC; Niu G; Zhu H; Lu G; Chen X J Nucl Med; 2018 Dec; 59(12):1809-1816. PubMed ID: 29700127 [No Abstract] [Full Text] [Related]
4. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients. Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390 [TBL] [Abstract][Full Text] [Related]
5. A pilot study imaging integrin αvβ3 with RGD PET/CT in suspected lung cancer patients. Gao S; Wu H; Li W; Zhao S; Teng X; Lu H; Hu X; Wang S; Yu J; Yuan S Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2029-37. PubMed ID: 26153145 [TBL] [Abstract][Full Text] [Related]
6. Inter-heterogeneity and intra-heterogeneity of α Kang F; Wang Z; Li G; Wang S; Liu D; Zhang M; Zhao M; Yang W; Wang J Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1520-1528. PubMed ID: 28405726 [TBL] [Abstract][Full Text] [Related]
7. Luan X; Huang Y; Gao S; Sun X; Wang S; Ma L; Teng X; Lu H; Yu J; Yuan S Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2336-2342. PubMed ID: 27631310 [TBL] [Abstract][Full Text] [Related]
8. Comparing the Differential Diagnostic Values of Du X; Zhang Y; Chen L; Mi B; You Q; Xu Y; Pan D; Wan W; Yang M; Yu C Contrast Media Mol Imaging; 2018; 2018():8194678. PubMed ID: 29670497 [TBL] [Abstract][Full Text] [Related]
9. Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer. Can C; Kepenek F; Kömek H; Gündoğan C; Kaplan İ; Taşdemir B; Güzel Y; Agüloğlu N; Karaoğlan H Nucl Med Commun; 2022 Oct; 43(10):1084-1091. PubMed ID: 35972340 [TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis at baseline identified by Wei Y; Qin X; Liu X; Zheng J; Luan X; Zhou Y; Yu J; Yuan S J Transl Med; 2022 Feb; 20(1):63. PubMed ID: 35109866 [TBL] [Abstract][Full Text] [Related]
11. Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal Metastases. Mi B; Yu C; Pan D; Yang M; Wan W; Niu G; Chen X Theranostics; 2015; 5(10):1115-21. PubMed ID: 26199649 [TBL] [Abstract][Full Text] [Related]
12. Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [ Dong Y; Wei Y; Chen G; Huang Y; Song P; Liu S; Zheng J; Cheng M; Yuan S Mol Imaging Biol; 2019 Feb; 21(1):175-182. PubMed ID: 29869060 [TBL] [Abstract][Full Text] [Related]
13. Wu J; Tian J; Zhang Y; Ji H; Sun J; Wang X; Sun C; Wang L; Teng Z; Lu G; Zhu H; Chen X Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2869-2876. PubMed ID: 35138445 [TBL] [Abstract][Full Text] [Related]
14. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma. Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of [ 68 Ga]Ga-Pentixafor versus [ 18 F]FDG PET/CTs in non-small cell lung cancer: a head-to-head comparative study. Mirshahvalad SA; Manafi-Farid R; Fallahi B; Seifi S; Geramifar P; Emami-Ardekani A; Eftekhari M; Beiki D Nucl Med Commun; 2023 Sep; 44(9):803-809. PubMed ID: 37334548 [TBL] [Abstract][Full Text] [Related]
16. PET/CT Imaging of NSCLC with a α Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741 [TBL] [Abstract][Full Text] [Related]
17. Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions. Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N Ann Nucl Med; 2009 Jul; 23(5):427-35. PubMed ID: 19437097 [TBL] [Abstract][Full Text] [Related]
18. [18F-FDG imaging by coincidence circuit SPECT with low-dose CT in preoperative assessment of pulmonary lesions]. Wang Q; Huang LL; Yue MG; Qin SL; Wang Y; Nie YX; Zhang CQ; Liang TJ; Zhao YM Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):924-7. PubMed ID: 17533745 [TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan. Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]